Top 10 Trending Penny Stocks for Friday, Feb. 4, 2022 (Sentiment via Swaggy Stocks)

2/4/22 3:52:05 PM ET

$AGTC

$CTXR

$GTE

$OP

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $AGTC alert in real time by email

SOC Telamed (TLMD)
Exela Technologies (XELA)
Senseonics (SENS)
Applied Genetic Technologies (AGTC)
Reed's (REED)
Citius Pharmaceuticals (CTXR)
OceanPal (OP)
Exicure (XCUR)
Veru (VERU)
Gran Tierra Energy (GTE)

https://swaggystocks.com/dashboard/stocks/hot-penny-stocks-list

Get the next $AGTC alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$AGTC
$CTXR
$GTE
$OP

Company	Date	Price Target	Rating	Analyst
Veru Inc. $VERU	5/14/2024	$5.00	Buy	B. Riley Securities
Veru Inc. $VERU	3/28/2024	$3.00	Outperform	Raymond James
Senseonics Holdings Inc. $SENS	7/19/2023	$0.50	Underperform	Jefferies
Veru Inc. $VERU	6/7/2023	$1.00	Underperform → Hold	Jefferies
Gran Tierra Energy Inc. $GTE	4/18/2022		Buy	Canaccord Genuity
SOC Telemed Inc. $TLMD	4/1/2022	$3.00	Neutral	Credit Suisse
Exela Technologies Inc. $XELA	3/23/2022	$3.00 → $0.55	Buy → Neutral	B. Riley Securities
SOC Telemed Inc. $TLMD	2/7/2022	$2.00 → $3.00	Neutral	Credit Suisse

More analyst ratings

$AGTC
$CTXR
$GTE
$OP
Leadership Updates

Live Leadership Updates

Rule 2.7 Announcement: Gran Tierra Energy to Acquire i3 Energy plc
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY RESTRICTED JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. THE FOLLOWING ANNOUNCEMENT IS AN ADVERTISEMENT AND NOT A PROSPECTUS OR CIRCULAR OR PROSPECTUS OR CIRCULAR EQUIVALENT DOCUMENT AND INVESTORS SHOULD NOT MAKE ANY INVESTMENT DECISION IN RELATION TO THE NEW GRAN TIERRA SHARES EXCEPT ON THE BASIS OF THE INFORMATION IN THE SCHEME DOCUMENT WHICH IS PROPOSED TO BE PUBLISHED IN DUE COURSE. NEITHER THIS ANNOUNCEMENT, NOR THE INFORMATION CONTAINED HEREIN, CONSTITUTE A SOLICITATION OF PROXIES WITHIN THE MEANING OF
8/19/24 7:06:17 PM ET
$GTE
Oil & Gas Production
Energy
Exela Technologies Reminds Stockholders to Cast Their Vote for Upcoming Annual Meeting of Stockholders to be held on June 13, 2024 at 10:00 a.m. Central Time
IRVING, Texas, June 12, 2024 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. ("Exela" or the "Company") (NASDAQ:XELA, XELAP))), a business process automation leader, today reminds its stockholders to vote ahead of the upcoming annual meeting of stockholders (the "Meeting"). The Meeting will be held online at www.virtualshareholdermeeting.com/XELA2024 on Thursday, June 13, at 10:00 AM CT. The Board of Directors of Exela unanimously recommends that the Company's stockholders vote (i) "FOR" each director nominee, (ii) for future advisory votes on executive compensation to occur every "1 Year" and (iii) "FOR" all other proposals. FOR ASSISTANCE WITH VOTING YOUR SHARES PLEASE CONTACT OUR PROXY SO
6/12/24 8:00:50 AM ET
$XELA
Business Services
Consumer Discretionary
Exela Technologies Reminds Stockholders to Cast Their Vote for Upcoming Annual Meeting of Stockholders to be held on June 13, 2024 at 10:00 a.m. Central Time
IRVING, Texas, June 04, 2024 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. ("Exela" or the "Company") (NASDAQ:XELA, XELAP))), a business process automation leader, today reminds its stockholders to vote ahead of the upcoming annual meeting of stockholders (the "Meeting"). The Meeting will be held online at www.virtualshareholdermeeting.com/XELA2024 on Thursday, June 13, at 10:00 AM CT. The Board of Directors of Exela unanimously recommends that the Company's stockholders vote (i) "FOR" each director nominee, (ii) for future advisory votes on executive compensation to occur every "1 Year" and (iii) "FOR" all other proposals. The Company urges all stockholders to exercise their right to vote
6/4/24 9:00:04 AM ET
$XELA
Business Services
Consumer Discretionary

Citius Pharmaceuticals, Inc. Announces 1-for-25 Reverse Stock Split
CRANFORD, N.J., Nov. 22, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (NASDAQ:CTXR) announced today that it will be executing a reverse stock split of its common stock, par value $0.001 per share, at a ratio of 1-for-25 ("Reverse Stock Split"). Pursuant to the laws of the State of Nevada and subject to prior approval by the Company's Board of Directors, Citius Pharma was not required to obtain shareholder approval to effectuate the Reverse Stock Split. The Reverse Stock Split will become effective at 5:00 pm Eastern Time on November 25, 2024. The Company's common stock will begin trading on the Nasdaq Capital Market on a split-adjusted basis beginning
11/22/24 9:00:00 AM ET
$CTXR
Biotechnology: Pharmaceutical Preparations
Health Care
Reed's to Participate at the Sidoti Conference on December 4
NORWALK, Conn., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Reed's, Inc. (OTCQX:REED) ("Reed's" or the "Company"), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, today announced its management team will participate in the upcoming Sidoti Conference being held virtually December 4-5, 2024. The team will hold 1x1 meetings throughout the day on December 4, and the Company's virtual presentation will be available at 1:00 p.m. ET on the same day. Please click here to register and view the on-demand presentation. To sign up for the conference or schedule a 1x1 meeting with the Reed's team, please visit www.sidoti.com/events. For any additional questions, please contact
11/20/24 5:10:05 PM ET
$REED
Beverages (Production/Distribution)
Consumer Staples
Citius Pharmaceuticals Announces Closing of $3 Million Registered Direct Offering
CRANFORD, N.J., Nov. 18, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (NASDAQ:CTXR) ("Citius Pharma" or the "Company"), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today closed its previously announced registered direct offering for the purchase of an aggregate of 12,000,000 shares of its common stock and accompanying warrants to purchase up to an aggregate of 12,000,000 shares of its common stock, at a purchase price of $0.25 per share and accompanying warrant. The warrants have an exercise price of $0.25 per share, are exercisable immediately upon issuance, and expire five years from the initial exercise date.
11/18/24 4:05:00 PM ET
$CTXR
Biotechnology: Pharmaceutical Preparations
Health Care

Exicure, Inc. Enters into Purchase Agreements for $1.3 Million and $8.7 Million Equity Financing and Reports Third Quarter 2024 Financial Results
Exicure, Inc. (NASDAQ:XCUR, the ", Company", )) has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. In September 2022, the Company announced a significant reduction in force, suspension of preclinical activities and halting of all research and development, and that the Company was exploring strategic alternatives to maximize stockholder value. Equity Financing In an agreement dated November 6, 2024 and executed on November 12, 2024, the Company agreed to sell and issue to HiTron Systems Inc. ("HiTron") 433,333 shares of common stock, par value $0.0001 per share, for $1.3 million, at
11/14/24 4:01:00 PM ET
$XCUR
Biotechnology: Pharmaceutical Preparations
Health Care
Reed's Reports Third Quarter 2024 Results and Provides Business Update
Strengthened Liquidity Position with New $10 Million Credit Facility and Assumption of Secured Notes by the Company's Majority Stockholder Management to Host Conference Call Today at 8:30 a.m. ET NORWALK, Conn., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Reed's, Inc. (OTCQX:REED) ("Reed's" or the "Company"), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, is reporting financial results for the three months ended September 30, 2024. The Company is also providing an update on recent strategic transactions, including the assumption of outstanding secured notes by the Company's majority stockholder, D&D Source of life Holding LTD ("D&D"). Q3 2024 Financial Highlight
11/14/24 7:00:57 AM ET
$REED
Beverages (Production/Distribution)
Consumer Staples
Reed's Schedules Third Quarter 2024 Conference Call for November 14 at 8:30 a.m. ET
NORWALK, Conn., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Reed's, Inc. (OTCQX:REED) ("Reed's" or the "Company"), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, will host a conference call on Thursday, November 14, 2024 at 8:30 a.m. Eastern time to discuss its financial results for the three months ended September 30, 2024. The Company's results will be reported in a press release prior to the call. Reed's management will host the conference call, followed by a question-and-answer period. Date: Thursday, November 14, 2024Time: 8:30 a.m. Eastern timeToll-free dial-in number: (800) 717-1738International dial-in number: (646) 307-1865Conference ID: 14622Webcast: Re
11/11/24 8:30:00 AM ET
$REED
Beverages (Production/Distribution)
Consumer Staples

Top 10 Trending Penny Stocks for Friday, Feb. 4, 2022 (Sentiment via Swaggy Stocks)

Chat with this insight

Recent Analyst Ratings for $AGTC$CTXR$GTE$OP

$AGTC$CTXR$GTE$OP Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Chief Financial Officer Ellson Ryan bought $75,480 worth of shares (12,000 units at $6.29), increasing direct ownership by 15% to 94,666 units (SEC Form 4)

Large owner Union Square Park Capital Management, Llc bought $796,808 worth of shares (531,205 units at $1.50) (SEC Form 4)

President and CEO Guidry Gary bought $617,000 worth of shares (100,000 units at $6.17), increasing direct ownership by 23% to 525,672 units (SEC Form 4)

$AGTC$CTXR$GTE$OP FDA approvals

Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

FDA Approval for ENTADFI issued to VERU INC

$AGTC$CTXR$GTE$OP Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Reeds Inc.

Amendment: SEC Form SC 13G/A filed by Gran Tierra Energy Inc.

Amendment: SEC Form SC 13G/A filed by Gran Tierra Energy Inc.

$AGTC$CTXR$GTE$OP Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Cogburn Ronald Clark was granted 80,908 shares, increasing direct ownership by 158,643% to 80,959 units (SEC Form 4)

Director Reynolds James was granted 884,827 shares (SEC Form 4)

Interim CFO Brown Matt was granted 33,025 shares, increasing direct ownership by 67,398% to 33,074 units (SEC Form 4)

$AGTC$CTXR$GTE$OP Market Insights

Live Market Insights

Exicure Shares Halted On Circuit Breaker To The Downside, Stock Now Up 70.5%

Exicure Shares Resume Trade

Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

$AGTC$CTXR$GTE$OP Leadership Updates

Live Leadership Updates

Rule 2.7 Announcement: Gran Tierra Energy to Acquire i3 Energy plc

Exela Technologies Reminds Stockholders to Cast Their Vote for Upcoming Annual Meeting of Stockholders to be held on June 13, 2024 at 10:00 a.m. Central Time

Exela Technologies Reminds Stockholders to Cast Their Vote for Upcoming Annual Meeting of Stockholders to be held on June 13, 2024 at 10:00 a.m. Central Time

$AGTC$CTXR$GTE$OP Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

B. Riley Securities initiated coverage on Veru with a new price target

Raymond James initiated coverage on Veru with a new price target

Jefferies initiated coverage on Senseonics with a new price target

$AGTC$CTXR$GTE$OP Press Releases

Fastest customizable press release news feed in the world

$AGTC$CTXR$GTE$OP Financials

Live finance-specific insights

$AGTC$CTXR$GTE$OP SEC Filings

Citius Pharmaceuticals, Inc. Announces 1-for-25 Reverse Stock Split

Reed's to Participate at the Sidoti Conference on December 4

Citius Pharmaceuticals Announces Closing of $3 Million Registered Direct Offering

Exicure, Inc. Enters into Purchase Agreements for $1.3 Million and $8.7 Million Equity Financing and Reports Third Quarter 2024 Financial Results

Reed's Reports Third Quarter 2024 Results and Provides Business Update

Reed's Schedules Third Quarter 2024 Conference Call for November 14 at 8:30 a.m. ET

SEC Form PRE 14A filed by Exicure Inc.

Exicure Inc. filed SEC Form 8-K: Other Events

Reeds Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

Recent Analyst Ratings for
$AGTC
$CTXR
$GTE
$OP

$AGTC
$CTXR
$GTE
$OP
Insider Purchases

$AGTC
$CTXR
$GTE
$OP
FDA approvals

$AGTC
$CTXR
$GTE
$OP
Large Ownership Changes

$AGTC
$CTXR
$GTE
$OP
Insider Trading

$AGTC
$CTXR
$GTE
$OP
Market Insights

$AGTC
$CTXR
$GTE
$OP
Leadership Updates

$AGTC
$CTXR
$GTE
$OP
Analyst Ratings

$AGTC
$CTXR
$GTE
$OP
Press Releases

$AGTC
$CTXR
$GTE
$OP
Financials

$AGTC
$CTXR
$GTE
$OP
SEC Filings